These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31646742)

  • 1. Magnetic resonance-guided radiation therapy: A review.
    Chin S; Eccles CL; McWilliam A; Chuter R; Walker E; Whitehurst P; Berresford J; Van Herk M; Hoskin PJ; Choudhury A
    J Med Imaging Radiat Oncol; 2020 Feb; 64(1):163-177. PubMed ID: 31646742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges.
    Chetty IJ; Doemer AJ; Dolan JL; Kim JP; Cunningham JM; Dragovic J; Feldman A; Walker EM; Elshaikh M; Adil K; Movsas B; Parikh PJ
    Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):950-967. PubMed ID: 35901978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical physics challenges in clinical MR-guided radiotherapy.
    Kurz C; Buizza G; Landry G; Kamp F; Rabe M; Paganelli C; Baroni G; Reiner M; Keall PJ; van den Berg CAT; Riboldi M
    Radiat Oncol; 2020 May; 15(1):93. PubMed ID: 32370788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
    Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
    Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
    Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
    Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
    Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
    JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical Radiotherapy Advances - The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation.
    Gough J; Hall W; Good J; Nash A; Aitken K
    Clin Oncol (R Coll Radiol); 2022 May; 34(5):301-312. PubMed ID: 35305888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
    Bruynzeel AME; Tetar SU; Oei SS; Senan S; Haasbeek CJA; Spoelstra FOB; Piet AHM; Meijnen P; Bakker van der Jagt MAB; Fraikin T; Slotman BJ; van Moorselaar RJA; Lagerwaard FJ
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1086-1094. PubMed ID: 31419510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrafraction Motion Management With MR-Guided Radiation Therapy.
    Fast MF; Cao M; Parikh P; Sonke JJ
    Semin Radiat Oncol; 2024 Jan; 34(1):92-106. PubMed ID: 38105098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy.
    Yadav P; Musunuru HB; Witt JS; Bassetti M; Bayouth J; Baschnagel AM
    Radiol Oncol; 2019 Sep; 53(3):362-368. PubMed ID: 31553704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A facility for magnetic resonance-guided radiation therapy.
    Jaffray DA; Carlone MC; Milosevic MF; Breen SL; Stanescu T; Rink A; Alasti H; Simeonov A; Sweitzer MC; Winter JD
    Semin Radiat Oncol; 2014 Jul; 24(3):193-5. PubMed ID: 24931091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance image guidance in external beam radiation therapy planning and delivery.
    Arivarasan I; Anuradha C; Subramanian S; Anantharaman A; Ramasubramanian V
    Jpn J Radiol; 2017 Aug; 35(8):417-426. PubMed ID: 28612288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Beam Therapy and Photon-Based Magnetic Resonance Image-Guided Radiation Therapy: The Next Frontiers of Radiation Therapy for Hepatocellular Carcinoma.
    Zaki P; Chuong MD; Schaub SK; Lo SS; Ibrahim M; Apisarnthanarax S
    Technol Cancer Res Treat; 2023; 22():15330338231206335. PubMed ID: 37908130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunity Is Knocking: The Need to Responsively and Responsibly Integrate Therapeutic MRI into Radiation Therapy.
    Erler D; D'Alimonte L; Campbell M
    J Med Imaging Radiat Sci; 2018 Mar; 49(1):16-17. PubMed ID: 30479281
    [No Abstract]   [Full Text] [Related]  

  • 17. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
    Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance-Guided Radiation Therapy for Head and Neck Cancers.
    Lavigne D; Ng SP; O'Sullivan B; Nguyen-Tan PF; Filion E; Létourneau-Guillon L; Fuller CD; Bahig H
    Curr Oncol; 2022 Oct; 29(11):8302-8315. PubMed ID: 36354715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance-guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system.
    Boldrini L; Colloca GF; Villani E; Chiloiro G; Bellieni A; Manfrida S; Cellini F; Gambacorta MA; Valentini V
    Tumori; 2021 Feb; 107(1):26-31. PubMed ID: 32410505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and longitudinal assessment of daily quality assurance for an MR-guided radiotherapy (MRgRT) linac.
    Mittauer KE; Dunkerley DAP; Yadav P; Bayouth JE
    J Appl Clin Med Phys; 2019 Nov; 20(11):27-36. PubMed ID: 31633882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.